Enhancement of μ opioid antinociception by oral Δ9- tetrahydrocannabinol: Dose-response analysis and receptor identification

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 2, 1999, Pages 859-867

  Cichewicz, Diana L ^a   Martin, Zachary L ^a   Smith, Forrest L ^a   Welch, Sandra P ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINALTORPHIMINE; DIAMORPHINE; HYDROMORPHONE; MU OPIATE RECEPTOR AGONIST; NALOXONE; OXYMORPHONE; PENTAZOCINE; PETHIDINE; TETRAHYDROCANNABINOL;

ANIMAL EXPERIMENT; ANTINOCICEPTION; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; MALE; MOUSE; NOCICEPTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TAIL FLICK TEST;

ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; MALE; MICE; MICE, INBRED ICR; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; REACTION TIME; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; SIGNAL TRANSDUCTION; TETRAHYDROCANNABINOL;

EID: 0032925678     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Bhargava HN (1991) Multiple opioid receptors of brain and spinal cord in opioid addiction. Gen Pharmacol 22:767-772.
2. Beal JE, Olson R, Lefkowitz L, Laubenstein L, Bellman P, Yangco B, Morales JO, Murphy R, Powderly W, Plasse TF, Mosdell KW and Shepard KV (1997) Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. J Pain Symptom Mgmt 14:7-14.
3. Chen Y, Mestek A, Liu J, Hurley JA and Yu L (1993) Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol Pharmacol 44:8-12.
4. Corchero J, Avila MA, Fuentes JA and Manzanares J (1997) Delta-9 tetrahydrocannabinol increases prodynorphin and proenkephalin gene expression in the spinal cord of the rat. Life Sci 61:PL39-PL43.
5. D'amour FE and Smith DL (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 7:274-279.
6. de Stoutz ND, Bruera E and Suarez-Almazor M (1995) Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Mgmt 10:378-384.
7. Ellison NM (1993) Opioid analgesics for cancer pain: Toxicities and their treatments, in Cancer Pain (Patt RB ed) pp185-194, JB Lippincott, Philadelphia.
8. Ghosh P and Bhattacharya SK (1979) Cannabis-induced potentiation of morphine analgesia in rat: Role of brain monoamines. Ind J Med Res 70:275.
9. Gutstein HB, Mansour A, Watson SJ, Akil H and Fields HL (1998) Mu and kappa opioid receptors in periaqueductal gray and rostral ventromedial medulla. Neuro-Report 9:1777-1781.
10. Harris LS and Pierson AK (1964) Some narcotic antagonists in the benzomorphan series. J Pharmacol Exp Ther 143:141-148.
11. Harris RA and Stokes JA (1982) Cannabinoids inhibit calcium uptake by brain synaptosomes. J Neurosci 2:443-447.
12. Kantor TG, Sunshine A, Laska E, Meisner M and Hopper M (1966) Oral analgesic studies: pentazocine hydrochloride codeine aspiring and placebo and their influence on response to placebo. Clin Pharmacol Ther 7:447-454.
13. Kieffer BL, Befort K, Gaveriaux-Ruff C and Hirth CJ (1992) The δ-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization. Neurobiology 89:12048-12052.
14. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC and Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (London) 346:561-564.
15. Mechoulam R, Lander N, Srebnik M, Zamir I, Breuer A, Shalita B, Dikstein S, Carlini EA, Leite JR, Edery H and Porath G (1984) Recent advances in the use of cannabinoids as therapeutic agents, in The Cannabinoids: Chemical Pharmacologic and Therapeutic Aspects (Agurell S, Dewey W and Willette R eds) pp 777-793, Academic Press, New York.
16. Munro S, Thomas KL and Abu-shaar (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature (London) 365:61-64.
17. Neil A (1984) Affinities of some common opioid analgesics towards four binding sites in mouse brain. Naunyn-Schmeidelberg's Arch Pharmakol 328:24-29.
18. Nelson KA, Walsh T and Deeter P (1994) A phase II study of delta-9 tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. J Pall Care 10:14-19.
19. Pan ZZ, Tershner SA and Fields HL (1997) Cellular mechanism for anti-analgesic action of agonists of the kappa opioid receptor. Nature (London) 389:382-385.
20. Porreca F, Takemori AE, Sultana M, Portoghese PS, Bowen WD and Mosberg HI (1992) Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors. J Pharmacol Exp Ther 263:147-152.
21. 9-tetrahydrocannabinol and morphine in the spinal cord. J Pharmacol Exp Ther 279:608-616.
22. Pugh G, Welch SP and Bass PP (1994) Modulation of free intracellular calcium and c-AMP by morphine and cannabinoids alone and in combination in mouse brain and spinal cord synaptosomes. Pharmacol Biochem Behav 49:1093-1100.
23. Reche I, Fuentes JA and Ruiz-Gayo M (1996a) A role for central cannabinoid and opioid systems in peripheral delta-9 tetrahydrocannabinol-induced analgesia in mice. Eur J Pharmacol 301:75-81.
24. Reche I, Fuentes JA and Ruiz-Gayo M (1996b) Potentiation of delta-9 tetrahydro-cannabinol-induced analgesia by morphine in mice: Involvement of mu- and kappa-opioid receptors. Eur J Pharmacol 318:11-16.
25. Richardson DE and Akil H (1977) Pain reduction by electrical brain stimulation in man (part 2): Chronic self-administration in the periventricular gray matter. J Neurosurg 47:184-194.
26. 9-tetrahydrocannabinol. Pharmacol Biochem Behav 60:559-566.
27. 9-tetrahydrocannabinol-induced analgesia. Brain Res 578:8-12.
28. Smith PB, Welch SP and Martin BR (1994) Interactions between 49-tetrahydrocannabinol and kappa opioids in mice. J Pharmacol Exp Ther 268:1382-1387.
29. Sofuoglu M, Portoghese PS and Takemori AE (1991) Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: Evidence for delta opioid receptor subtypes. J Pharmacol Exp Ther 257:676-680.
30. Takemori AE, Ho BY, Naeseth JS and Portoghese PS (1988) Norbinaltorphimine: A highly selective kappa -opioid antagonist in analgesic and receptor binding assays. J Pharmacol Exp Ther 246:255-258.
31. Tallarida RJ and Murray RB (1987) Procedures 6, 8, 9, 11, in Manual of Pharmacologic Calculations With Computer Programs. Springer-Verlag, New York.
32. Timpone JG, Wright DJ, Li N, Egorin MJ, Enama ME, Mayers J and Galetto G (1997) The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome. AIDS Res Hum Retroviruses 13:305-315.
33. Vree TB and Verwey-van-Wissen CP (1992) Pharmacokinetics and metabolism of codeine in humans. Biopharm Drug Dispos 13:445-460.
34. Welch SP (1993) Modulation of cannabinoid-induced antinociception by norbinaltorphimine but not ICI 174,864 in mice. J Pharmacol Exp Ther 266:633-640.
35. Welch SP and Stevens DL (1992) Antinociceptive activity of intrathecally administered cannabinoids alone and in combination with morphine in mice. J Pharmacol Exp Ther 262:10-18.
36. Welch SP, Thomas C and Patrick GS (1995) Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: Possible mechanisms for interaction with morphine. J Pharmacol Exp Ther 272:310-321.
37. Yamamoto H, Harris RA, Loh HH and Way EL (1978) Effects of acute and chronic morphine treatments on calcium localization and binding in the brain. J Pharmacol Exp Ther 205:255-264.
38. Yasuda K, Raynor K, Haeyoung K, Breder CD, Takeda J, Reisine T and Bell GI (1993) Cloning and functional comparison of κ and δ opioid receptors from mouse brain. Neurobiology 90:6736-6740.
39. Zachariou V and Goldstein BD (1996) Delta-opioid receptor modulation of the release of substance P-like immunoreactivity in the dorsal horn of the rat following mechanical or thermal noxious stimulation. Brain Res 736:305-314.